PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1679323
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1679323
According to Stratistics MRC, the Global Ostomy Drainage Bags Market is accounted for $1.86 billion in 2024 and is expected to reach $2.52 billion by 2030 growing at a CAGR of 5.2% during the forecast period. Patients who have had ostomy surgery, such as a colostomy, ileostomy, or urostomy, use ostomy drainage bags. When the body is unable to eliminate waste materials normally through the digestive or urinary systems, these bags are used to collect waste products like stool or pee. Ostomy drainage bags are available in one-piece and two-piece systems and are made for comfort, convenience, and hygiene. For ostomy patients, they offer vital care that enhances quality of life and guards against infection.
According to the World Ageing 2019 report, in 2019, there were around 703 million people aged 65 years or more in the world. According to Nicolas Patel, in an article published in 2020, inflammatory bowel disease is most prevalent in South America at approximately 21%, and least prevalent in Southeast Asia at 7%.
Rising incidence of gastrointestinal and urological disorders
The need for ostomy drainage bags is being driven by the rising prevalence of gastrointestinal and urological conditions, including bladder cancer, inflammatory bowel disease, and colorectal cancer. Ostomy drainage bags must be used for waste collection because these illnesses frequently necessitate surgical procedures that create a stoma. The growing prevalence of these disorders, particularly among the aging population, contributes to the market's expansion. The availability of cutting-edge ostomy products and improvements in surgical procedures also contribute to the market's expansion.
Skin irritation and allergic reactions
Skin irritation and allergic reactions are common challenges associated with the use of ostomy drainage bags. Prolonged contact with the skin can lead to irritation, rashes, and allergic responses, causing discomfort and potential complications for patients. These issues can impact patient compliance and satisfaction with ostomy care products. Manufacturers are continuously working to develop more skin-friendly materials and designs to mitigate these problems. However, the risk of skin irritation and allergic reactions remains a significant restraint to the market's growth.
Rising prevalence of obesity
Obesity is a risk factor for various gastrointestinal and urological disorders, foremost to an increased need for surgical interventions and ostomy care. The growing number of obese individuals seeking medical treatment drives the demand for ostomy drainage bags. Additionally, the focus on improving patient outcomes and quality of life for obese patients supports the adoption of advanced ostomy products. As a result, the rising prevalence of obesity presents significant opportunities for the market's growth.
Competition from alternative products
The ostomy drainage bags market faces competition from alternative products, such as absorbent products and other waste management solutions. These alternatives may offer different benefits, such as reduced skin irritation or improved convenience, attracting potential customers away from traditional ostomy drainage bags. The availability of a variety of options can impact market share and growth prospects for ostomy drainage bags. Manufacturers need to innovate and differentiate their products to stay competitive in the market.
Covid-19 Impact
The COVID-19 pandemic originally had a negative effect on the market for ostomy drainage bags because it caused interruptions in supply chains, production, and healthcare services. Elective surgery delays and fewer hospital stays resulted in a short-term decline in ostomy product demand. Nonetheless, demand increased as healthcare institutions adjusted, especially as telemedicine and homecare options expanded. As patients became more knowledgeable about ostomy management, the post-pandemic period saw a steady rebound and expansion.
The urostomy bags segment is expected to be the largest during the forecast period
The urostomy bags segment is expected to account for the largest market share during the forecast period, driven by the rising incidence of urological conditions include congenital urinary abnormalities, bladder cancer, and urine incontinence. The patient experience is being enhanced by developments in urostomy bag technology, such as increased comfort, discrete designs, and improved skin protection. Additional factors driving the market's expansion include an aging population, an increase in urostomy procedures, and greater awareness of urostomy care.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to the high number of ostomy surgeries performed in clinical settings. Increased cases of colorectal cancer, urological conditions, and other gastrointestinal diseases contribute to the demand for ostomy bags. Additionally, hospitals provide critical post-operative care and patient education, boosting product adoption. The growing focus on patient comfort, safety, and advanced surgical techniques further drives the demand for ostomy drainage bags in hospitals.
During the forecast period, Asia Pacific region is expected to hold the largest market share, due to the rising prevalence of chronic diseases like colorectal cancer and urological disorders. Increasing healthcare infrastructure, improved access to ostomy care, and greater patient awareness contribute to market growth. The aging population, coupled with advancements in ostomy product designs offering comfort and convenience, further fuel demand. Additionally, the growing focus on enhancing healthcare services in countries like India and China supports market expansion.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare infrastructure, widespread insurance coverage, and increasing awareness about ostomy care contribute to market growth. Moreover, technological advancements in ostomy products, such as improved comfort, skin protection, and discreet designs, further boost demand.
Key players in the market
Some of the key players profiled in the Ostomy Drainage Bags Market include Coloplast A/S, Hollister Incorporated, B. Braun Melsungen AG, Convatec Group PLC, Smith & Nephew, Medline Industries, Inc., 3M Health Care, Asid Bonz, Novartis AG, Hogy Medical Co., Ltd., Alcare Co., Ltd., Genairex, Inc., Vogt Medical, Marlen Manufacturing & Development Co., Lohmann & Rauscher GmbH & Co. KG, Surgical Appliance Industries, and Molnlycke Health Care.
In February 2025, Novartis announced that it has entered into an agreement to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical company with abelacimab, a late-stage medicine in development for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
In October 2024, Convatec collaborates with AbbVie for VYALEV(TM) therapy for the treatment of advanced Parkinson's disease in the United States. Convatec welcomes further regulatory approvals to support our collaboration with AbbVie, a leading global biopharmaceutical company.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.